Gui Zhi Fu Ling Wan (GZFLW), originally documented in the Jin Kui Yao Lue (Synopsis of Golden Chamber) by Zhang Zhongjing during the Han Dynasty, has evolved from a classical formula into a cornerstone of modern gynecological and circulatory therapy. In the current global pharmaceutical landscape, GZFLW is recognized as one of the most commercially successful traditional formulas, bridging the gap between ancient wisdom and modern clinical validation.
The global market for GZFLW has seen a compound annual growth rate (CAGR) of over 8% in the last five years. This surge is driven by the increasing integration of Traditional Chinese Medicine (TCM) into mainstream health systems in North America, Europe, and Southeast Asia. As a premier China Gui Zhi Fu Ling Wan exporter, we have observed a shift from traditional raw herb decoctions to high-purity granules and concentrated capsules, which meet the rigorous safety and efficacy standards required by international medical institutions.
The TCM industry is undergoing a "Quality Revolution." Global enterprise procurement now prioritizes traceability—from GAP-certified (Good Agricultural Practice) planting bases to GMP-compliant extraction. The trend is moving toward "Smart TCM," where AI and big data are used to standardize the active ingredients of Gui Zhi Fu Ling Wan, ensuring that every batch delivered by exporters maintains consistent therapeutic potency.
Global procurement needs are no longer restricted to local herb shops. Today, hospital groups, pharmaceutical wholesalers, and private medical clinics in the US, Australia, and the UK are seeking direct partnerships with Chinese factories to secure bulk supply chains that are compliant with FDA and EMA heavy metal and pesticide residue regulations.
Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. was founded in 2023, and has been adhering to the developing concept of the parent company, NGP, which has always stood strong in the face of inheriting and popularizing the millennial-long TCM culture with modern techniques. We have served many regions around the world, including traditional Chinese medicine clinics, herbal extract wholesalers, medical institutions, and clinics. "We are committed to empowering global pharmacies through an efficient B2B supply chain to safeguard health."
In Western markets, GZFLW is extensively used in integrative clinics for managing uterine fibroids, ovarian cysts, and endometriosis. Our localized granule forms allow for easy prescription and patient compliance.
Applied in scenarios involving blood stasis, athletes and physical therapy centers use Gui Zhi Fu Ling derivatives to enhance blood circulation and speed up recovery from chronic stasis-related injuries.
Global pharmaceutical companies procure high-grade GZFLW extracts for secondary drug development, utilizing our standardized powder as the active pharmaceutical ingredient (API).
With the rise of "Food as Medicine" in Asian-Pacific regions, standardized GZFLW capsules are becoming a staple in high-end wellness pharmacies for health maintenance.
Vertical Integration: Unlike many exporters, NGP operates the entire value chain. From the 300+ planting bases across China to our intelligent extraction facility in Sichuan, we ensure that the Cinnamon Twig (Gui Zhi) and Poria (Fu Ling) are harvested at peak potency.
R&D Strength: Founded in 2009, Sichuan Neo-Green Pharmaceutical is one of only six pilot manufacturers approved by the Chinese government for TCM granules. Our US subsidiary allows for localized customer service and rapid logistics within North America.
Technological Leadership: We utilize ultra-low temperature extraction and spray drying technologies to preserve the volatile oils and active components of the Gui Zhi Fu Ling Wan formula, a feat often lost in traditional manufacturing processes.
Contact us today to receive our latest product catalog and wholesale pricing for Gui Zhi Fu Ling Wan and other professional TCM solutions.
Inquiry Now